Results 101 to 110 of about 37,273 (171)

Clinical Outcomes of High-Dose Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Bousamri A, Al-Shehri M, Mestarihi M, Almutairi TB, Alaredhi M, Mahanna B, Alharbi F.   +6 more
europepmc   +1 more source

Multimodal imaging and intravitreal faricimab for polypoidal choroidal vasculopathy associated with a choroidal nevus in genetically confirmed Usher syndrome type 2: a case report. [PDF]

BMC Ophthalmol
Kim J, Choi J, Kim K, Yu SY.
europepmc   +1 more source

Juxtapillary choroidal excavation with polypoidal choroidal vasculopathy: An unusual association

Indian Journal of Ophthalmology, 2019
Maitreyi Chowdhury, Pukhraj Rishi
doaj   +1 more source

Associations of <i>TNFRSF10A</i> with Central Serous Chorioretinopathy, Polypoidal Choroidal Vasculopathy, and Age-Related Macular Degeneration. [PDF]

Ophthalmol Sci
Chen ZJ, Yu J, Ng DSC, Ho M, Zhu X, Brelen ME, Young AL, Yam JC, Tham CC, Pang CP, Chen LJ.   +10 more
europepmc   +1 more source

Peripheral exudative hemorrhagic chorioretinopathy as a variant of polypoidal choroidal vasculopathy in a case series of Chinese patients. [PDF]

Int J Ophthalmol
Wang JX, Zhou N, Yang LH, Wei WB.
europepmc   +1 more source

Polypoidal Choroidal Vasculopathy

Ophthalmology Retina
Min Wang, Simon S. Gao, Yali Jia
  +4 more sources

Predictors of response to bevacizumab monotherapy in polypoidal choroidal vasculopathy: a 12-month retrospective study. [PDF]

Int J Retina Vitreous
Montrisuksirikun C, Pongrujikorn S, Rodanant N, Thoongsuwan S, Prakhunhungsit S, Wongchaisuwat N, Phasukkijwatana N.   +6 more
europepmc   +1 more source

REGIONAL VARIABILITY IN CHOROIDAL VASCULARITY INDEX AND ASSOCIATION WITH INTERVORTEX ANASTOMOSES IN POLYPOIDAL CHOROIDAL VASCULOPATHY. [PDF]

Retina
Chong YJ, Chong Teo KY, Gilead N, Akiba M, Cheung CMG.   +4 more
europepmc   +1 more source

Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab. [PDF]

J Clin Med
Spindler J, Pfister IB, Weinberger A, Garweg JG.   +3 more
europepmc   +1 more source

Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]

PLoS One
Yoshinaga A, Kitamoto K, Aoki S, Terao R, Inoue T, Obata R, Azuma K.   +6 more
europepmc   +1 more source